Literature DB >> 7925915

Chronic lung diseases and the perception of breathlessness: a clinical perspective.

J G Burdon1, M C Pain, A R Rubinfeld, A Nana.   

Abstract

Breathlessness is an extremely common symptom. Its genesis is incompletely understood but is known to be largely determined by many of the mechanical factors associated with the act of breathing. As with all subjective sensations various other factors including volition, behavioural style and other cortical and subcortical factors play a part in its genesis. The relief of breathlessness is primarily directed at the underlying disorder. In those conditions and situations where specific therapy has little to offer or little impact it is reasonable to consider ways of reducing the perception of breathlessness by pharmacological means. However, to date there is no convincing evidence that use of drugs in the pursuit of the relief of breathlessness has any specific effect in modifying the perception of this often distressing symptom. Any reduction in breathlessness achieved in this way can be adequately explained in terms of a reduction in ventilation and other indices of respiratory mechanics.

Entities:  

Mesh:

Year:  1994        PMID: 7925915     DOI: 10.1183/09031936.94.07071342

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.

Authors:  R Leung; P Hill; J Burdon
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 2.  Management of dyspnea in patients with chronic obstructive pulmonary disease.

Authors:  Amy P Abernethy; Hope E Uronis; Jane L Wheeler; David C Currow
Journal:  Wien Med Wochenschr       Date:  2009-12

3.  Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study.

Authors:  C P Van Schayck; J M C Loozen; E Wagena; R P Akkermans; G J Wesseling
Journal:  BMJ       Date:  2002-06-08

Review 4.  An approach to dyspnea in advanced disease.

Authors:  Romayne Gallagher
Journal:  Can Fam Physician       Date:  2003-12       Impact factor: 3.275

5.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06

Review 6.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

7.  Early COPD Diagnosis in Family Medicine Practice: How to Implement Spirometry?

Authors:  Nathalie Saad; Maria Sedeno; Katrina Metz; Jean Bourbeau
Journal:  Int J Family Med       Date:  2014-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.